Catheter ablation of atrial fibrillation: An update

Laurent M. Haegeli, Hugh Calkins

Research output: Contribution to journalArticle

Abstract

Catheter ablation of atrial fibrillation (AF) isnow animportant therapeutic modality for patients with AF. Thereis considerable evidence available from several prospective randomized trials demonstrating that catheter ablation of AF issuperiorto antiarrhythmic drug therapyincontrolling AF and that AF ablation improves quality of life substantially. This is especially true for patients with paroxysmal AF without other severe comorbidities. Catheter ablation is indicated for treatment of patients with symptomatic AF in whom one or more attempts at class 1 or 3 antiarrhythmic drug therapy have failed. Although current guidelines state that is appropriate to perform catheter ablation as a first-line therapy in selected patients, in our clinical practice this is rare. This reflects a number of important realities concerning the field of AF ablation. Catheter ablation of AF is a challenging and complex procedure, which is not free of the risk of potentially life-threatening complications, such as an atriooesophageal fistula, stroke, and cardiac tamponade. Although these major complications are rare and their rate is falling, they must be considered by both patients and physicians. The progress made and the new developmentsonthe horizon in the field of AF catheter ablation are remarkable. When radiofrequency catheter ablation was first introduced in the late 1980s, few would have predicted that catheter ablation of AF would emerge as the most commonly performed ablation procedure in most major hospitals.

Original languageEnglish (US)
Pages (from-to)2454-2459b
JournalEuropean Heart Journal
Volume35
Issue number36
DOIs
StatePublished - 2014

Fingerprint

Catheter Ablation
Atrial Fibrillation
Anti-Arrhythmia Agents
Accidental Falls
Cardiac Tamponade
Fistula
Comorbidity
Therapeutics
Stroke
Quality of Life
Guidelines
Physicians

Keywords

  • Atrial fibrillation
  • Catheter ablation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Catheter ablation of atrial fibrillation : An update. / Haegeli, Laurent M.; Calkins, Hugh.

In: European Heart Journal, Vol. 35, No. 36, 2014, p. 2454-2459b.

Research output: Contribution to journalArticle

Haegeli, Laurent M. ; Calkins, Hugh. / Catheter ablation of atrial fibrillation : An update. In: European Heart Journal. 2014 ; Vol. 35, No. 36. pp. 2454-2459b.
@article{57abed1705324203b0b2a8402f695683,
title = "Catheter ablation of atrial fibrillation: An update",
abstract = "Catheter ablation of atrial fibrillation (AF) isnow animportant therapeutic modality for patients with AF. Thereis considerable evidence available from several prospective randomized trials demonstrating that catheter ablation of AF issuperiorto antiarrhythmic drug therapyincontrolling AF and that AF ablation improves quality of life substantially. This is especially true for patients with paroxysmal AF without other severe comorbidities. Catheter ablation is indicated for treatment of patients with symptomatic AF in whom one or more attempts at class 1 or 3 antiarrhythmic drug therapy have failed. Although current guidelines state that is appropriate to perform catheter ablation as a first-line therapy in selected patients, in our clinical practice this is rare. This reflects a number of important realities concerning the field of AF ablation. Catheter ablation of AF is a challenging and complex procedure, which is not free of the risk of potentially life-threatening complications, such as an atriooesophageal fistula, stroke, and cardiac tamponade. Although these major complications are rare and their rate is falling, they must be considered by both patients and physicians. The progress made and the new developmentsonthe horizon in the field of AF catheter ablation are remarkable. When radiofrequency catheter ablation was first introduced in the late 1980s, few would have predicted that catheter ablation of AF would emerge as the most commonly performed ablation procedure in most major hospitals.",
keywords = "Atrial fibrillation, Catheter ablation",
author = "Haegeli, {Laurent M.} and Hugh Calkins",
year = "2014",
doi = "10.1093/eurheartj/ehu291",
language = "English (US)",
volume = "35",
pages = "2454--2459b",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "36",

}

TY - JOUR

T1 - Catheter ablation of atrial fibrillation

T2 - An update

AU - Haegeli, Laurent M.

AU - Calkins, Hugh

PY - 2014

Y1 - 2014

N2 - Catheter ablation of atrial fibrillation (AF) isnow animportant therapeutic modality for patients with AF. Thereis considerable evidence available from several prospective randomized trials demonstrating that catheter ablation of AF issuperiorto antiarrhythmic drug therapyincontrolling AF and that AF ablation improves quality of life substantially. This is especially true for patients with paroxysmal AF without other severe comorbidities. Catheter ablation is indicated for treatment of patients with symptomatic AF in whom one or more attempts at class 1 or 3 antiarrhythmic drug therapy have failed. Although current guidelines state that is appropriate to perform catheter ablation as a first-line therapy in selected patients, in our clinical practice this is rare. This reflects a number of important realities concerning the field of AF ablation. Catheter ablation of AF is a challenging and complex procedure, which is not free of the risk of potentially life-threatening complications, such as an atriooesophageal fistula, stroke, and cardiac tamponade. Although these major complications are rare and their rate is falling, they must be considered by both patients and physicians. The progress made and the new developmentsonthe horizon in the field of AF catheter ablation are remarkable. When radiofrequency catheter ablation was first introduced in the late 1980s, few would have predicted that catheter ablation of AF would emerge as the most commonly performed ablation procedure in most major hospitals.

AB - Catheter ablation of atrial fibrillation (AF) isnow animportant therapeutic modality for patients with AF. Thereis considerable evidence available from several prospective randomized trials demonstrating that catheter ablation of AF issuperiorto antiarrhythmic drug therapyincontrolling AF and that AF ablation improves quality of life substantially. This is especially true for patients with paroxysmal AF without other severe comorbidities. Catheter ablation is indicated for treatment of patients with symptomatic AF in whom one or more attempts at class 1 or 3 antiarrhythmic drug therapy have failed. Although current guidelines state that is appropriate to perform catheter ablation as a first-line therapy in selected patients, in our clinical practice this is rare. This reflects a number of important realities concerning the field of AF ablation. Catheter ablation of AF is a challenging and complex procedure, which is not free of the risk of potentially life-threatening complications, such as an atriooesophageal fistula, stroke, and cardiac tamponade. Although these major complications are rare and their rate is falling, they must be considered by both patients and physicians. The progress made and the new developmentsonthe horizon in the field of AF catheter ablation are remarkable. When radiofrequency catheter ablation was first introduced in the late 1980s, few would have predicted that catheter ablation of AF would emerge as the most commonly performed ablation procedure in most major hospitals.

KW - Atrial fibrillation

KW - Catheter ablation

UR - http://www.scopus.com/inward/record.url?scp=84925313756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925313756&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehu291

DO - 10.1093/eurheartj/ehu291

M3 - Article

C2 - 25053659

AN - SCOPUS:84925313756

VL - 35

SP - 2454-2459b

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 36

ER -